“There are a few common problems impacting the nutraceutical industry right now and they usually fall into at least one of the following categories: (1) products are poorly formulated and contain a lot of filler ingredients; (2) the ingredients are great but poorly absorbed by the body; or (3) the ingredients, and the delivery mechanism is sound, but the cost makes them unreachable for most,” says Faraaz Jamal. “We look forward to launching a new differentiated offering that brings an exciting formulation, combined with an effective, affordable delivery system that substantially increases the bioavailability of our product.”
“Entering into a global market with a distinctive offering is exciting,” said Meni Morim, CEO of Namaste. “I find immense possibilities to combine our new nutraceuticals offering with our cannabis portfolio as the cannabis regulations mature. Having the potential opportunity to expand our nutraceutical business with micro doses of THC and CBD will open up new pathways and innovative products that haven’t been seen before.”